Owler

JUNE 14, 2023

In Series A Funding Italy-based biotech company Aavantgarde Bio expressed that its initial focus following its successful funding round is to utilize the $65.3M Get the Owler Google Chrome extension for quick access to company data, competitor information and insights in one easy click. AAVantgarde Bio Raised $65.3M

Biotech 52

Biotech Startups Capital Research 52

Alpha Sense BI

MAY 5, 2023

Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97

Biotech Capital Banking Startups 97

Alpha Sense BI

AUGUST 30, 2023

In practice, quantamental research for asset management means using AI to mine and analyze massive amounts of data for insight, while also depending on the knowledge of particular companies, expert commentary, and other anecdotal insights that are essential for informing decisions.

Management 98

Management Biotech Due Diligence Algorithm 98

ArchIntel

JUNE 9, 2021

Earlier in his career, Fields worked as a conference and marketing coordinator at EBD Group, an organizer of biotech and medical device events. Information gathered 24/7 is delivered via the ArchIntel Daily Intelligence Brief in a newsletter format by email and through a private online archive at www.archintel.com.

Competitive 104

Competitive Competitive Intelligence Biotech Briefing 104

BIS Research

MARCH 19, 2019

This growth of the market is aided by the impressive growth in the digital health and information technology market. The precision medicine market by ecosystem is further sub-segmented under applied sciences, precision diagnostics, digital health, and information technology, and precision therapeutics.

Globalization 64

Globalization Biotech Marketing Marketing 64

Wink Intel

FEBRUARY 23, 2021

tech and biotech ETFs and two fixed income components. For more information, please visit www.american-equity.com. BofAS indices and related information, the name “BofAS”, and related trademarks, are intellectual property licensed from BofAS, and may not be copied, used, or distributed without BofAS’ prior written approval.

Intellectual Property 40

Intellectual Property Biotech Banking Retail 40

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

APRIL 29, 2024

The Transformative Effect of Generative AI By 2025, it is estimated that more than 75% of venture capital (VC) and early-stage investor executive reviews will be informed using artificial intelligence (AI) and data analytics. Sectors Leading Funding Activity In Q1 2024, VC-backed deals totaled 3,205 in the US.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

JANUARY 26, 2024

Morgan’s Annual Healthcare Conference is the industry’s largest, most informative healthcare investment symposium. This is highly significant insights and information for both the research community and the clinical community. It’s the next generation of flow cytometry and digital pathology put into 1 instrument.” “And

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

SEPTEMBER 1, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs. In the age of information overload, you need reliable resources of insights to act quickly.

Pharmaceutical 52

Pharmaceutical Biotech Market Intelligence Competitive 52

Alpha Sense BI

APRIL 19, 2024

But in today’s age of information overload, finding the right insights and cutting through the noise is a nearly impossible task. That’s why you need a tool that does all the heavy lifting for you, so you can focus on leveraging and analyzing information rather than searching for it.

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Alpha Sense BI

APRIL 12, 2024

A seasoned analyst is one who has mastered the art of expert call interviews to ensure each interview is extracting premium quality insights that accurately inform the user’s investment process. First-hand perspectives from industry experts are valuable resources because experience matters when making fully informed investment decisions.

Primary Research 52

Primary Research Advantage Advantage Research 52

CIO

JULY 17, 2023

With every company being digital, CIOs will take on the role of the architect of the company, not just the architect of digital,” says Vipin Gupta, former chief information, strategy and digital officer at Toyota Financial Services International and the 2021 MIT Sloan CIO Leadership Award Winner.

Biotech 617

Biotech Innovation Technology Technology 617

Alpha Sense BI

MARCH 13, 2024

According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs. In January, Roche completed the $2.7 Streamline your research workflow, gain the competitive edge, and uncover new opportunities with AlphaSense.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 28, 2023

It requires constant sifting through the ever-expanding supply of available information, as well as finding relevant insights amidst the noise. Third Bridge also recognizes that value chain information is typically fragmented, unqualified, and outdated. That’s where expert networks come in.

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52

Happy Market

MAY 9, 2022

Jamin Brazil: Let’s start with some context, tell us a little bit about your parents and how they inform what you do today. [00:11:40]. And we were watching overnight how the quality of that information was declining, right? John Dick: Yes, glad to be here, love the podcast, thanks for having me. [00:11:38].

Management 52

Management Entertainment Market Research Marketing Research 52